ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
22.58
+0.42 (1.90%)
Mar 9, 2026, 4:00 PM EDT - Market closed
ACADIA Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 177.7 | 319.59 | 188.66 | 114.85 | 147.44 | Upgrade
|
| Short-Term Investments | 641.99 | 436.4 | 250.21 | 301.98 | 373.27 | Upgrade
|
| Cash & Short-Term Investments | 819.69 | 755.99 | 438.87 | 416.82 | 520.71 | Upgrade
|
| Cash Growth | 8.43% | 72.26% | 5.29% | -19.95% | -17.60% | Upgrade
|
| Accounts Receivable | 121.46 | 98.74 | 98.27 | 62.2 | 64.37 | Upgrade
|
| Other Receivables | 26.77 | 5.96 | 4.08 | 0.89 | 0.98 | Upgrade
|
| Receivables | 148.23 | 104.7 | 102.35 | 63.08 | 65.34 | Upgrade
|
| Inventory | 34.67 | 21.95 | 35.82 | 6.64 | 7.88 | Upgrade
|
| Prepaid Expenses | 59.53 | 55.68 | 39.09 | 21.4 | 23.89 | Upgrade
|
| Total Current Assets | 1,062 | 938.32 | 616.13 | 507.94 | 617.82 | Upgrade
|
| Property, Plant & Equipment | 54.87 | 50.79 | 56.47 | 61.59 | 66.32 | Upgrade
|
| Long-Term Investments | - | - | - | - | 3.6 | Upgrade
|
| Other Intangible Assets | 108.89 | 119.78 | 65.49 | - | - | Upgrade
|
| Long-Term Deferred Tax Assets | 249.88 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | 88.45 | 78.87 | 10.87 | 18.28 | 12.38 | Upgrade
|
| Total Assets | 1,564 | 1,188 | 748.96 | 587.81 | 700.12 | Upgrade
|
| Accounts Payable | 10.9 | 16.19 | 17.54 | 12.75 | 6.88 | Upgrade
|
| Accrued Expenses | 254.27 | 254.44 | 196.16 | 103.58 | 80.89 | Upgrade
|
| Current Portion of Leases | 11.63 | 9.96 | 9.41 | 9.31 | 8.3 | Upgrade
|
| Current Income Taxes Payable | 0.3 | 12.02 | 1.56 | - | - | Upgrade
|
| Other Current Liabilities | - | 102.26 | 29.58 | - | - | Upgrade
|
| Total Current Liabilities | 277.11 | 394.87 | 254.25 | 125.63 | 96.07 | Upgrade
|
| Long-Term Leases | 40.55 | 42.04 | 47.8 | 52.7 | 56.13 | Upgrade
|
| Other Long-Term Liabilities | 19.14 | 18.06 | 15.15 | 9.07 | 7.03 | Upgrade
|
| Total Liabilities | 336.81 | 454.96 | 317.2 | 187.4 | 159.23 | Upgrade
|
| Common Stock | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 3,039 | 2,937 | 2,863 | 2,771 | 2,695 | Upgrade
|
| Retained Earnings | -1,813 | -2,204 | -2,431 | -2,370 | -2,154 | Upgrade
|
| Comprehensive Income & Other | 1.45 | 0.29 | 0.02 | -0.98 | -0.19 | Upgrade
|
| Shareholders' Equity | 1,227 | 732.79 | 431.76 | 400.41 | 540.89 | Upgrade
|
| Total Liabilities & Equity | 1,564 | 1,188 | 748.96 | 587.81 | 700.12 | Upgrade
|
| Total Debt | 52.19 | 52 | 57.21 | 62 | 64.43 | Upgrade
|
| Net Cash (Debt) | 767.5 | 704 | 381.66 | 354.82 | 456.28 | Upgrade
|
| Net Cash Growth | 9.02% | 84.46% | 7.56% | -22.23% | -21.66% | Upgrade
|
| Net Cash Per Share | 4.52 | 4.23 | 2.33 | 2.19 | 2.84 | Upgrade
|
| Filing Date Shares Outstanding | 170.49 | 166.79 | 164.77 | 162.23 | 161.2 | Upgrade
|
| Total Common Shares Outstanding | 170.31 | 166.71 | 164.65 | 162.06 | 161.01 | Upgrade
|
| Working Capital | 785 | 543.45 | 361.87 | 382.31 | 521.76 | Upgrade
|
| Book Value Per Share | 7.21 | 4.40 | 2.62 | 2.47 | 3.36 | Upgrade
|
| Tangible Book Value | 1,118 | 613.01 | 366.27 | 400.41 | 540.89 | Upgrade
|
| Tangible Book Value Per Share | 6.57 | 3.68 | 2.22 | 2.47 | 3.36 | Upgrade
|
| Machinery | 9.09 | 10.16 | 10.42 | 10.42 | 10.54 | Upgrade
|
| Construction In Progress | 3.26 | 0.52 | - | - | - | Upgrade
|
| Leasehold Improvements | 4.64 | 3.75 | 3.75 | 3.7 | 3.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.